Jean Bourbeau Selected Research

Obstructive Lung Diseases (Obstructive Lung Disease)

1/2022	Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study.
4/2021	Dyspnoea and symptom burden in mild-moderate COPD: the Canadian Cohort Obstructive Lung Disease Study.
1/2021	Effect of type and dosage of newly prescribed inhaled corticosteroids on obstructive lung disease and pneumonia hospitalisations in older individuals with asthma, COPD or both: a retrospective study of health administrative data.
12/2020	Normative Peak Cardiopulmonary Exercise Test Responses in Canadian Adults Aged ≥40 Years.
10/2020	Granularity of SERPINA1 alleles by DNA sequencing in CanCOLD.
1/2020	Fractional Exhaled Nitric Oxide as an Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease (COPD) with or without Concurrent Diagnosis of Asthma: The Canadian Cohort Obstructive Lung Disease (CanCOLD).
1/2017	Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.
11/2016	The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean Bourbeau Research Topics

Disease

104	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2002
17	Dyspnea (Shortness of Breath) 01/2022 - 10/2004
14	Asthma (Bronchial Asthma) 01/2021 - 03/2002
8	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2022 - 11/2016
7	Inflammation (Inflammations) 02/2021 - 11/2007
4	Pneumonia (Pneumonitis) 01/2021 - 05/2013
4	Hypoxia (Hypoxemia) 01/2020 - 03/2011
3	Muscular Atrophy (Muscle Atrophy) 01/2022 - 12/2013
2	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2022 - 12/2020
2	Atrophy 01/2022 - 01/2018
2	Emphysema 12/2021 - 10/2018
2	Cough 01/2021 - 04/2015
2	Infections 01/2021 - 05/2003
2	Disease Progression 06/2010 - 09/2009
2	Respiratory Insufficiency (Respiratory Failure) 07/2004 - 05/2003
1	Chronic Cough 01/2021
1	Chronic Bronchitis 01/2021
1	Neoplasms (Cancer) 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	COVID-19 12/2020
1	Insulin Resistance 01/2020
1	Frailty 01/2018
1	Death (Near-Death Experience) 01/2016

Drug/Important Bio-Agent (IBA)

21	GoldIBA 01/2022 - 04/2011
20	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 05/2003
19	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 04/2003
11	SmokeIBA 01/2022 - 11/2011
10	Oxygen (Dioxygen)IBA 01/2020 - 06/2005
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2011 - 05/2003
5	SteroidsIBA 09/2009 - 05/2003
4	Messenger RNA (mRNA)IBA 01/2021 - 04/2007
4	Salmeterol Xinafoate (Serevent)FDA Link 01/2016 - 11/2004
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2007
4	Prednisone (Sone)FDA LinkGeneric 01/2016 - 10/2009
4	CytokinesIBA 11/2011 - 05/2003
3	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 06/2010
3	Tiotropium Bromide (Spiriva)FDA Link 01/2021 - 11/2004
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 12/2017
3	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 01/2016 - 08/2012
3	Opioid Analgesics (Opioids)IBA 06/2015 - 03/2011
3	vilanterolIBA 01/2015 - 05/2013
3	fluticasone furoate FDA Link 01/2015 - 05/2013
3	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 03/2014 - 11/2004
2	Particulate MatterIBA 01/2022 - 01/2021
2	Nitrogen DioxideIBA 01/2022 - 01/2021
2	Azithromycin (Zithromax)FDA LinkGeneric 02/2021 - 01/2018
2	tiotropium-olodaterolIBA 01/2021 - 10/2018
2	Clostridium perfringens epsilon-toxinIBA 12/2020 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2016
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2016 - 11/2007
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2016 - 03/2011
2	Albuterol (Salbutamol)FDA LinkGeneric 01/2016 - 12/2012
2	Adenosine Diphosphate (ADP)IBA 03/2011 - 11/2008
1	ElementsIBA 05/2022
1	Carbon MonoxideIBA 12/2021
1	A-factor (Streptomyces)IBA 10/2021
1	MacrolidesIBA 02/2021
1	SootIBA 01/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	Muscarinic AntagonistsIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Unithiol (DMPS)IBA 01/2021
1	NemiralisibIBA 01/2021
1	LipidsIBA 01/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 10/2018
1	CannabidiolIBA 10/2018
1	Dronabinol (THC)FDA LinkGeneric 10/2018
1	GlucocorticoidsIBA 06/2018
1	Prostaglandins AIBA 01/2018
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2018
1	Saline SolutionIBA 01/2018
1	Carboxylesterase (Hydrolase S)IBA 01/2018
1	Furosemide (Lasix)FDA LinkGeneric 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 10/2017
1	inosine dialdehyde (inox)IBA 01/2017
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 01/2016
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2016
1	nintedanibIBA 01/2016
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2016
1	mitochondrial transcription factor AIBA 01/2016

Therapy/Procedure

27	Therapeutics 02/2021 - 05/2003
5	Drug Therapy (Chemotherapy) 01/2021 - 05/2003
5	Nebulizers and Vaporizers (Inhaler) 01/2021 - 08/2002
3	Long-Term Care 05/2022 - 02/2004
3	Terminal Care (Care, Terminal) 12/2018 - 05/2003
3	Exercise Therapy (Therapy, Exercise) 01/2017 - 05/2003
2	Denervation 01/2022 - 01/2018
2	Continuity of Patient Care 01/2019 - 05/2013
2	Patient Readmission 01/2019 - 01/2016
2	Ambulatory Care (Outpatient Care) 01/2018 - 04/2015
2	Precision Medicine 01/2018 - 01/2016
1	Critical Care (Surgical Intensive Care) 12/2020
1	Patient Transfer (Patient Dumping) 01/2020
1	Patient Care Bundles 01/2018
1	Role Playing (Playing, Role) 01/2018
1	Lasers (Laser) 01/2016